Loading...
XNYS
AGL
Market cap1.93bUSD
Jul 09, Last price  
115.67USD
1D
3.47%
1Q
508.15%
IPO
-99.38%
Name

agilon health inc

Chart & Performance

D1W1MN
XNYS:AGL chart
P/E
P/S
0.33
EPS
Div Yield, %
Shrs. gr., 5y
1.47%
Rev. gr., 5y
37.24%
Revenues
5.93b
-2.11%
794,411,0001,218,333,0001,521,494,0002,388,220,0004,316,363,0006,060,530,0005,932,576,000
Net income
-405m
L+55.81%
-282,588,000-60,052,000-406,487,000-106,553,000-262,596,000-260,151,000-405,347,000
CFO
-106m
L+83.05%
-103,861,000-53,204,000-148,159,000-130,808,000-156,199,000-57,777,000-105,763,000
Dividend
Nov 16, 20110.45 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
IPO date
Apr 15, 2021
Employees
747
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT